EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

COVID ‐19 as a Potential Trigger for Tuberculosis: Insights From a Large‐Scale Japanese Insurance Database Analysis

Daisuke Miyamori iD, Kotaro Ikeda iD, Sachi Nagasaka, Masanori Ito

Journal of General and Family Medicine · 2026-07 · 27 (4)

DOI: 10.1002/jgf2.70139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General and Family Medicine, online erschienen am 02.06.2026. Verfasst von Daisuke Miyamori und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Internal Medicine Hiroshima University Hospital Hiroshima Japan. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The long‐term impact of COVID‐19 on tuberculosis (TB) is concerning. This study assessed whether COVID‐19 was associated with an increased risk of active TB treatment risk in Japan using a nationwide propensity score–matched cohort design.

Methods

A retrospective cohort study used Japan's National Insurance Database from January 2020 to December 2022. COVID‐19 patients were matched 1:1 with controls using propensity scores based on age, sex, immunosuppressants use, Charlson comorbidity index, related medical conditions, healthcare utilization and prior TB history. The primary outcome was initiation of isoniazid‐based therapy plus rifampin with a TB‐related ICD‐10 diagnosis code. Cox proportional hazards models estimated hazard ratios (HRs) for COVID‐19's effect on TB treatment initiation.

Results

After matching, 3,097,422 individuals were included per group. During 8‐month median follow‐up, 886 participants initiated TB treatment. The HR among COVID‐19 infected individuals was 4.14 (95% CI: 3.51–4.89) versus matched controls. Subgroup analyses showed interaction between prior TB history and COVID‐19, with HR of 14.7 (5.35–40.2) in those with prior TB history, versus those without (HR 3.84, 95% CI 3.24–4.54). Risk remained elevated in participants without hospitalization (HR 3.96, 95% CI 3.35–4.68).

Conclusions

This study provides robust population‐based evidence demonstrating a moderate association between prior COVID‐19 and subsequent initiation of active tuberculosis treatment, particularly in those with prior TB history.

Schlagwörter

Stichwörter der Autor:innen

COVID‐19National Insurance Databasepropensity score matchingtuberculosis

Autor:innen und Institutionen

  • Department of General Internal Medicine Hiroshima University Hospital Hiroshima Japan.

ORCID-Profile: Daisuke Miyamori, Kotaro Ikeda

Zitieren

APA

Miyamori, D., Ikeda, K., Nagasaka, S., & Ito, M. (2026). COVID ‐19 as a Potential Trigger for Tuberculosis: Insights From a Large‐Scale Japanese Insurance Database Analysis. Journal of General and Family Medicine, 27(4). https://doi.org/10.1002/jgf2.70139

Vancouver

Miyamori D, Ikeda K, Nagasaka S, Ito M. COVID ‐19 as a Potential Trigger for Tuberculosis: Insights From a Large‐Scale Japanese Insurance Database Analysis. Journal of General and Family Medicine. 2026;27(4). doi:10.1002/jgf2.70139

BibTeX
@article{Miyamori2026,
  author = {Miyamori, Daisuke and Ikeda, Kotaro and Nagasaka, Sachi and Ito, Masanori},
  title = {COVID ‐19 as a Potential Trigger for Tuberculosis: Insights From a Large‐Scale Japanese Insurance Database Analysis},
  journal = {Journal of General and Family Medicine},
  year = {2026},
  volume = {27},
  number = {4},
  doi = {10.1002/jgf2.70139}
}
Kostenlos starten →